staurosporine has been researched along with Bile Duct Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ai, Z; Bo, X; Gao, Z; Liu, H; Pan, H; Shen, S; Suo, T; Wang, J; Wang, Y; Zhang, D | 1 |
1 other study(ies) available for staurosporine and Bile Duct Neoplasms
| Article | Year |
|---|---|
Stathmin decreases cholangiocarcinoma cell line sensitivity to staurosporine-triggered apoptosis via the induction of ERK and Akt signaling.
Topics: Apoptosis; Bile Duct Neoplasms; Blotting, Western; Cell Line, Tumor; Cells, Cultured; Cholangiocarcinoma; Electrophoresis, Gel, Two-Dimensional; Enzyme Induction; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Integrin beta1; Protein Kinase C; Proteomics; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Stathmin; Staurosporine | 2017 |